FOXM1-depleted mice display significantly compromised tumor growth and metastasis [7], whereas FOXM1 overexpression contributes to poor prognosis in patients with lung adenocarcinomas, meningioma and acute lymphoblastic leukemia. This evidence concerns the gene FOXM1 and acute lymphoblastic leukemia.